Results From a Pilot Study of an Automated Directly Observed Therapy Intervention Using Artificial Intelligence With Conditional Economic Incentives Among Young Adults With HIV.

IF 2.9 3区 医学 Q3 IMMUNOLOGY
Marie C D Stoner, Louis Smith, Kristin Ming, Noah Mancuso, Henna Patani, Adam Sukhija-Cohen, Yancy Granados, Danielle Wagner, Mallory O Johnson, Sue Napierala, Torsten B Neilands, Parya Saberi
{"title":"Results From a Pilot Study of an Automated Directly Observed Therapy Intervention Using Artificial Intelligence With Conditional Economic Incentives Among Young Adults With HIV.","authors":"Marie C D Stoner, Louis Smith, Kristin Ming, Noah Mancuso, Henna Patani, Adam Sukhija-Cohen, Yancy Granados, Danielle Wagner, Mallory O Johnson, Sue Napierala, Torsten B Neilands, Parya Saberi","doi":"10.1097/QAI.0000000000003397","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Despite improvements in antiretroviral therapy (ART) availability, suboptimal adherence is common among youth with HIV (YWH) and can increase drug resistance and poor clinical outcomes. Our study examined an innovative mobile app-based intervention that used automated directly observed therapy (aDOT) using artificial intelligence, along with conditional economic incentives (CEIs) to improve ART adherence and enhance viral suppression among YWH.</p><p><strong>Setting: </strong>We conducted a pilot study of the aDOT-CEI intervention, informed by the operant framework of Key Principles in Contingency Management Implementation, to improve ART adherence among YWH (18-29) in California and Florida who had an unsuppressed HIV viral load.</p><p><strong>Methods: </strong>We recruited 28 virally unsuppressed YWH from AIDS Healthcare Foundation clinics, who used the aDOT platform for 3 months. Study outcomes included feasibility and acceptability, self-reported ART adherence, and HIV viral load.</p><p><strong>Results: </strong>Participants reported high satisfaction with the app (91%), and 82% said that it helped them take their medication. Comfort with the security and privacy of the app was moderate (55%), and 59% indicated the incentives helped improve daily adherence.</p><p><strong>Conclusions: </strong>Acceptability and feasibility of the aDOT-CEI intervention were high with potential to improve viral suppression, although some a priori metrics were not met. Pilot results suggest refinements which may improve intervention outcomes, including increased incentive amounts, provision of additional information, and reassurance about app privacy and security. Additional research is recommended to test the efficacy of the aDOT-CEI intervention to improve viral suppression in a larger sample.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11108745/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003397","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Despite improvements in antiretroviral therapy (ART) availability, suboptimal adherence is common among youth with HIV (YWH) and can increase drug resistance and poor clinical outcomes. Our study examined an innovative mobile app-based intervention that used automated directly observed therapy (aDOT) using artificial intelligence, along with conditional economic incentives (CEIs) to improve ART adherence and enhance viral suppression among YWH.

Setting: We conducted a pilot study of the aDOT-CEI intervention, informed by the operant framework of Key Principles in Contingency Management Implementation, to improve ART adherence among YWH (18-29) in California and Florida who had an unsuppressed HIV viral load.

Methods: We recruited 28 virally unsuppressed YWH from AIDS Healthcare Foundation clinics, who used the aDOT platform for 3 months. Study outcomes included feasibility and acceptability, self-reported ART adherence, and HIV viral load.

Results: Participants reported high satisfaction with the app (91%), and 82% said that it helped them take their medication. Comfort with the security and privacy of the app was moderate (55%), and 59% indicated the incentives helped improve daily adherence.

Conclusions: Acceptability and feasibility of the aDOT-CEI intervention were high with potential to improve viral suppression, although some a priori metrics were not met. Pilot results suggest refinements which may improve intervention outcomes, including increased incentive amounts, provision of additional information, and reassurance about app privacy and security. Additional research is recommended to test the efficacy of the aDOT-CEI intervention to improve viral suppression in a larger sample.

利用人工智能和有条件的经济激励措施,对感染艾滋病毒的年轻成年人进行自动直接观察治疗干预的试点研究结果。
背景:尽管抗逆转录病毒疗法(ART)的可用性有所改善,但在感染艾滋病病毒的青少年(YWH)中,不达标的依从性很常见,而且会增加耐药性和不良临床结果。我们的研究考察了一种基于移动应用程序的创新干预措施,该措施利用人工智能的自动直接观察疗法(aDOT)和有条件的经济激励措施(CEIs)来改善抗逆转录病毒疗法的依从性并提高青年艾滋病感染者的病毒抑制率:我们对 aDOT-CEI 干预进行了一项试点研究,该研究借鉴了 "权宜管理实施关键原则 "的操作性框架,旨在改善加利福尼亚州和佛罗里达州未抑制 HIV 病毒载量的青年艾滋病患者(18-29 岁)坚持抗逆转录病毒疗法的情况:我们从艾滋病医疗基金会(AHF)诊所招募了 28 名病毒载量未受抑制的青年艾滋病患者,他们使用 aDOT 平台 3 个月。研究结果包括可行性和可接受性、自我报告的抗逆转录病毒疗法依从性以及艾滋病病毒载量:结果:参与者对该应用的满意度很高(91%),82%的人表示该应用有助于他们服药。对应用程序的安全性和私密性的满意度适中(55%),59%的人表示激励措施有助于改善日常坚持服药的情况:aDOT-CEI干预的可接受性和可行性都很高,具有改善病毒抑制的潜力,尽管有些先验指标没有达到。试点结果表明,改进措施可提高干预效果,包括增加奖励金额、提供更多信息以及保证应用程序的隐私和安全。建议开展更多研究,以测试 aDOT-CEI 干预措施在更大样本中提高病毒抑制率的效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信